PEOPLE - Changes at Horizon Medical Products (US):
This article was originally published in Clinica
Executive Summary
In connection with its agreement with Medtronic and Comvest Venture Partners, Horizon Medical Products (Atlanta, Georgia) has appointed Comvest's Robert Priddy, Robert Wenzel and a third as-yet undisclosed candidate to the board. The new members replace Gordon Tunstall, William Peterson and Ross Arnold. Horizon's Chairman and CEO Marshall Hunt said "this extension and new board structure will allow us to focus on continued revenue growth, profitability and new product development in the oncology marketplace". Horizon is a designer, developer, manufacturer and commercialiser of percutaneous vascular and spinal access systems.
You may also be interested in...
Second EU MDR Notified Body Designated In France
Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.
Takeda, Astellas Found New JV To Support Japanese Bioventures
Major Japanese companies Takeda, Astellas and SMBC are joining hands to establish a new joint venture with $3.9m capital and based in Japan’s largest biocluster Shonan iPark to help incubate local biopharma start-ups.
Could Eledon’s Anti-CD40L Change Transplant Medicine?
Eledon Pharmaceuticals’ CD40 Ligand blocker has yielded impressive results for post-transplant immunosuppression and cutting-edge transplant doctors have also used it for pig-to-human kidney and heart transplants, opening up the field of xenotransplantation.